← Eichor
Study identifier: NCT07105202 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Shorter Weaning From Invasive Ventilation With Levosimendan

Condition: Mechanical Ventilation · Weaning Failure  ·  Sponsor: Radboud University Medical Center

PhasePhase 4
Planned participants250
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Prolonged weaning from mechanical ventilation is a common and serious challenge in the ICU, associated with increased morbidity, mortality, and length of stay. Diaphragm dysfunction plays a key role in weaning failure, and current strategies to support respiratory muscle function are limited. Levosimendan is a calcium sensitizer that enhances cardiac and skeletal muscle contractility, including the diaphragm, without increasing oxygen demand. The investigators hypothesize that treatment with Levosimendan in difficult-to-wean ICU patients will improve diaphragm function and thereby shorten the duration of mechanical ventilation compared to placebo.

This description comes directly from the study's public registry record.

Talk to the study team

Esther de Leijer, MD  ·  +31243668420  ·  esther.deleijer@radboudumc.nl

Leo Heunks, MD, PhD  ·  leo.heunks@radboudumc.nl

Always discuss trial participation with your own doctor first.

Locations (8)

Rijnstate Ziekenhuis StichtingArnhem, Gelderland, NetherlandsRecruiting
Intensive Care Medicine, Radboud UniversityNijmegen, Gelderland, NetherlandsRecruiting
Canisius Wilhelmina ZiekenhuisNijmegen, Gelderland, NetherlandsRecruiting
Jeroen Bosch Ziekenhuis Stichting's-Hertogenbosch, North Brabant, NetherlandsRecruiting
Catharina Ziekenhuis StichtingEindhoven, North Brabant, NetherlandsNot Yet Recruiting
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Rotterdam, South Holland, NetherlandsNot Yet Recruiting
Sint Franciscus Vlietland Groep StichtingRotterdam, South Holland, NetherlandsRecruiting
Maasstad Ziekenhuis StichtingRotterdam, South Holland, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07105202